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In vitro antimicrobial susceptibility of ceftriax-
one/sulbactam/ethylenediaminetetraacetic acid
and comparison to other
beta-lactam/beta-lactamase inhibitors,
carbapenems and colistin against gram
negative bacteria
S. Jain ∗, A. Gupta, V. Khare
Max Hospital, Shalimar Bagh, Delhi, India
Background: Drug resistance against Gram Negative Bacte-
ria (GNB) is increasing. Incidence of ESBL producing bacteria is
around 70-80%. Carbapenem resistance has also been reached
40-90% for the GNB. We are also obtaining Colistin resistant
isolates. Resistance against Beta-lactam (BL)/beta-lactamase
inhibitor (BLI) combinations is already very high. No new antibi-
otic or antibiotic group is in pipeline at least for the next
5-10 years. With this background the objective of this study
is to compare in vitro susceptibility of new BL/BLI combina-
tion Ceftriaxone/Sulbactam/Ethylenediaminetetraacetic Acid
(CSE) to Piperacillin/Tazobactam, Cefoperazone/Sulbactam,
Cefepime/Tazobactam, Meropenem, Imipenem and Colistin.
Methods & Materials: Study was conducted on all clin-
ical samples received from all critical care units between
January 2014 and June 2015. Identiﬁcation and susceptibil-
ity was done by Vitek 2 compact system. Susceptibilities
of Ceftriaxone/Sulbactam/Ethylenediaminetetraacetic Acid and
Cefepime/Tazobactam were done by disc diffusion method on
the bases of CLSI guidelines. Escherichia coli, Klebsiella sp., Pseu-
domonas sp. and Acinetobacter sp. isolates were included in the
study.
Results: Escherichia coli (324, 25%) was the most common bac-
teria isolated followed by Klebsiella sp. (309, 24%), Pseudomonas
sp. (217, 17%) and Acinetobacter sp. (214, 17%) from all clinical
samples. % Susceptibilities were as given in table below.
Organism Number
of isolates
CSE Cefepime/
Tazobactam
Piperacillin/
Tazobactam
Cefoperazone/
Sulbactam
Meropenem Imipenem Colistin
Escherichia coli 324 67.4 77.3 46.5 57.9 73.1 72.7 99.5
Klebsiella sp. 309 28.3 37.6 18.6 26.2 32 32 70.9
Pseudomonas sp. 217 43.1 64.1 40.6 46.9 52.4 50.3 93.8
Acinetobacter sp. 214 24.3 13.9 11.3 23.6 12.5 11.8 95.8
Conclusion: Colistin was the most sensitive antimicrobial for
all GNB. Carbapenem resistance was around 27% - 89%. CSE
susceptibility was better than Piperacillin/Tazobactam and Cefop-
erazone/Sulbactam and comparable toMeropenem and Imipenem.
Although the number of isolates included in this study were less in
number, a larger study needs to be conducted. This is an in vitro
susceptibility data hence study has to be conducted for clinical
efﬁciency of CSE.
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Antimicrobial susceptibility and serotype
distribution of invasive and non-invasive
streptococcus pneumoniae isolates and
comparison from healthy carriers
S. Jain1,∗, B.K. Das1, S. Tyagi1, A. Kapil 1, R.
Chaudhry1, S. Sood1, S.K. Kabra1, D. Nair2
1 All India Institute of Medical Sciences, New Delhi,
Delhi, India
2 Vardmann Mahavir Medical college & Safdarjung
Hospital, New Delhi, India
Background: Streptococcus pneumoniae is amajor cause ofmor-
bidity and mortality in developing countries. S. pneumoniae as a
commensal in nasopharynxplays a signiﬁcant role in infection. This
study was undertaken to determine the antimicrobial susceptibil-
ity pattern and serotype distribution of S. pneumoniae isolates from
invasive & non invasive infection and correlate it with isolates from
commensal nasopharyngeal ﬂora to ascertain their role in infection
in our population.
Methods & Materials: S. pneumoniae isolates from Blood/CSF
and respiratory secretions (sputum, BAL and nasopharyngeal
swab/throat swab) were analyzed to determine serotype and
antimicrobial susceptibility pattern. Serotyping was performed
by the quellung reaction. Antimicrobial susceptibility testing
was determined using disk diffusion method against the fol-
lowing antibiotics: Penicillin (1g oxacillin), Amoxicillin (1g),
Amox-clav (30g), Vancomycin (30g), Erythromycin (15g),
Tetracycline (30g), Levoﬂoxacin (5g), Oﬂoxacin (5g), Gati-
ﬂoxacin (5g), Trimethoprim-sulfamethoxazole (1.25/23.75g),
Chloramphenicol (30g), Linezolid (30g) as per CLSI guidelines.
Minimum inhibitory concentration was determined using E-test
for penicillin. S. pneumoniae ATCC 49619 was used as a control.
Results: A total of 31 isolates were collected including 11 from
sputum, 15 from throat swab/nasopharyngeal swab, 1 from BAL
and 4 from CSF. Invasive isolates belonged to serotypes 14, 3 & 15B.
Themost frequent serotypes among isolates obtained from sputum
were 7, 22 & 35. Isolates from nasopharyngeal swab/throat swab
belonged to serotypes 6, 19, 1 & 11 out of which serotype 6 was
the most common. Two isolates were non-typable. Out of 31 pneu-
mococcal isolates 3(9.6%), 7 (22.5%) and 28 (90.3%) were resistant
to penicillin, erythromycin and trimethoprim-sulfamethoxazole
respectively. Oxacillin resistant isolates were further tested for
penicillin susceptibility by E-test. All 3 oxacillin resistant isolates
demonstrated intermediate resistance topenicillin. These3 isolates
were non-invasive. All isolates were susceptible to vancomycin,
linezolid & amoxicillin-clavullinic acid. It is difﬁcult to isolate inva-
sive S. pneumoniae from clinical samples therefore non-invasive
isolates fromsputumcanbegoodsurrogate for antibiotic resistance
monitory.
Conclusion: In present study although the number of isolates
are small, increase in the incidence of penicillin resistance is wor-
risome. There is a need to monitor penicillin resistance among
invasive & non-invasive pneumococcal isolates. Our study implies
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the importance of continuous screening of serotypes & antimicro-
bial susceptibility pattern of S. pneumoniae isolates.
http://dx.doi.org/10.1016/j.ijid.2016.02.252
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Healthy carriage of drug resistant
Enterobacteriaceae in the community
V.M. Joy ∗, S. Bansal, N. Batra, G. didwal, A.
Thakur, V. Gautam, P. Ray, M. Gupta
Post Graduate Institute of Medical Education and
Research, Chandigarh, India
Background: The emergence of resistance in the normal ﬂora is
a major concern in the management of both hospital and commu-
nity acquired infections. The prevalence of the resistant organisms
in the community is on the rise. The selection pressure is causing
colonization resistance leading to blurring of distinction between
community and hospital environments. Thus this study was con-
ducted to ﬁnd out the prevalence of resistant organisms in the
normal ﬂora of healthy population.
Methods & Materials: A community based surveillance was
done from August to October, 2015. 207 stool samples were col-
lected from the residents of Burail. The population under study
was evenly distributed amongst paediatric and adult age groups.
The samples were inoculated on antibiotic containing media
which included cefotaxime, ceftazidime, cefepime, ciproﬂoxacin,
imipenem, meropenem, amikacin and gentamicin. Molecular
methods included multiplex PCR targeting TEM, OXA-1, CTXM-1,
SHV and VIM genes.
Results: Out of the total number of 207 stool samples, E. coliwas
the predominant isolate followed by K. pneumoniae, Enterobacter
species andMorganellamorgannii. The resistance to cephalosporins
was observed to be highest in E. coli (56%), followed by K. pneu-
moniae(0.04%). TEM was the predominant ESBL (34.9%) followed
by OXA-1 (26%), CTXM1 (21.2%) and SHV (6.8%). Three samples
grew CRE with VIM as the carbapenemase in one isolate only.
Other antibiotics to which these isolates were resistant included
ﬂuoroquinolones (42%) wherein E. coli accounted for 40%; and
aminoglycosides (0.01%). Eleven isolates (0.05%) were found to be
multidrug resistant ofwhich E. coli accounted for 0.04% andK. pneu-
moniae (0.01%).
Conclusion: The community based surveillance shows thepres-
enceof antimicrobial resistancebeingpresent in thenormal colonic
ﬂora. Majority of the population under study was neither on prior
antibiotic therapy nor hospitalized in the past 1 year. E. coli was
the predominant isolate obtained with the maximum resistance to
cephalosporins. ESBLwas the commonestmechanism of resistance
with TEM being the most prevalent.
http://dx.doi.org/10.1016/j.ijid.2016.02.253
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Epidemiology of extended-spectrum
beta-lactamase- and carbapenemase-producing
bacteria in stool from apparently healthy
children, South Africa
M. Kaba1,∗, R.I. Manenzhe1, C. Moodley1, H.J.
Zar2, M.P. Nicol1
1 University of Cape Town, Cape Town, Western
Cape, South Africa
2 University of Cape Town, Cape Town, South Africa
Background: We aimed to determine the prevalence and
genetic characteristics of extended-spectrum beta-lactamase
(ESBL)- and carbapenemase-producing Enterobacteriaceae in
stools from healthy infants and their mothers, and to determine
the risk factors associated with their carriage.
Methods & Materials: This study was nested within the Drak-
enstein Child Health Study, South Africa. Maternal and infant
faecal samples were collected at birth and at two additional
time-points from the infants. Samples were screened for ESBLs
and carbapenemase-producing organisms using ChromID ESBL
and ChromID CARBA media, respectively. Vitek 2 was used
for antibiotic susceptibility testing and identiﬁcation of suspect
ESBL/carbapenemase-producing isolates. ESBL production was
conﬁrmed using the combination disc test, and carbapenemase
production using the modiﬁed Hodge test. Selected ESBL and car-
bapenemase genes were characterized by singleplex polymerase
chain reaction and Sanger sequencing.
Results: Maternal faecal carriage of ESBL-producing bacteria
was 4.4%; 4/90 (95% conﬁdence interval (CI): 1.5%–10.2%), and
that of infants at birth was 3.5%; 4/116 (95% CI: 1.2%–8.0%). The
infant faecal carriage of ESBL-producing bacteria at 5-12 and 20-
28 weeks was 4.4%; 3/68 (95% CI: 1.3%–11.3%) and 5.7%; 2/35
(95% CI: 1.2%–17.1%), respectively. ESBL genes were detected
in six K. pneumoniae (blaCTX-M-15), ﬁve E. cloacae (blaSHV-12 and
blaSHV-5) and three E. coli (blaCTX-M-14) isolates. No carbapenemase-
producing bacteria were identiﬁed in this study. Pulsed-ﬁeld
gel electrophoresis showed heterogeneous clones of CTX-M-15-
producing K. pneumoniae isolates. In contrast, in a mother-infant
pair, we observed clonal relations among ESBL-producing E. cloacae
isolates. In addition, one infant was persistently colonized by SHV-
12-producing E. cloacae. Univariate analysis showed that infants
born to HIV-positive mother, via elective caesarean section, and
medication use before discharge were positively associated with
ESBL faecal carriage. In contrast, breastfeeding prior to discharge
was negatively associated with ESBL carriage.
Conclusion: This is theﬁrst study to detect ESBL-producing bac-
teria inhumanmeconiumsamples inAfrica, and raisesquestionson
the source of such isolates and implications for community trans-
mission. Further research is required to determine the spread of
ESBL- and carbapenemase-producing bacteria in community set-
tings in South Africa.
http://dx.doi.org/10.1016/j.ijid.2016.02.254
